GlaxoSmithKline PLC (GSK.L)
|Market Cap (Mil.):||£79,813.84|
|Shares Outstanding (Mil.):||4,859.29|
TOKYO/BEIJING - Three employees at one of Marubeni Corp's grain trading units in China have been detained by authorities, the Japanese trading house said on Thursday, a move sources told Reuters was prompted by allegations the unit evaded taxes on soy bean imports.
LONDON - The loud welcome given by investors to this week's deal for Novartis and GlaxoSmithKline to trade more than $20 billion of assets could trigger more pacts in the pharmaceuticals sector and beyond.
LONDON, April 23 - The loud welcome given by investors to this week's deal for Novartis and GlaxoSmithKline to trade more than $20 billion of assets could trigger more pacts in the pharmaceuticals sector and beyond.
April 23 - (The following statement was released by the rating agency)
April 23 - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
ZURICH/LONDON - Novartis and GlaxoSmithKline agreed to trade more than $20 billion worth of assets on Tuesday to bolster their best businesses and exit weaker ones as the drug industry contends with healthcare spending cuts and generic competition. | Video
* Deals, plus talk of Pfizer-Astra deal, lift sector shares (Adds details on Lilly animal health unit, updates share movement)
* Indexes extend gains after strong consumer confidence data
* FTSE 100 gains 0.9 pct * AstraZeneca surges on report of Pfizer approach * GlaxoSmithKline jumps on asset swap with Novartis (Updates with closing prices, adds technical detail) By Alistair Smout LONDON, April 22 - Corporate activity in the pharmaceutical sector on Tuesday pushed Britain's benchmark stock index to a two-week high and to within sight of a peak for this year. Drugmaker AstraZeneca rose 4.7 percent, with trading volumes in the stock more than three
* FTSE 100 up 1.1 pct * AstraZeneca surges on reported Pfizer bid interest * GlaxoSmithKline jumps on asset swap with Novartis (Adds detail, quote, updates prices) By Alistair Smout LONDON, April 22 - Merger and acquisition activity among drug companies drove Britain's top share index to a two-week high on Tuesday, putting it within sight of its peak for 2014. Drugmaker AstraZeneca surged 6.7 percent, with trading volumes in the stock over twice its 90-day average
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
"The Economy Matters" Report for GSK: the economy's impact on GSK's price and risk, featuring the powerful Economic Climate Rating
Provider: MacroRisk Analytics/EconomicInvestor
Provider: S&P Capital IQ – STARS Reports
GlaxoSmithKline PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.